Diagnostica molecolare e gene editing basati su CRISPR.
| Date | Round | Amount |
|---|---|---|
| Nov 2025 | Bridge CrisprBits raised $3M in a pre-Series A led by Spectrum Impact to commercialize the PathCrisp diagnostic platform. | $3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.